XML 56 R43.htm IDEA: XBRL DOCUMENT v3.22.1
COMMON STOCK PURCHASE WARRANTS (Tables)
12 Months Ended
Dec. 31, 2021
Common Stock Purchase Warrants  
SCHEDULE OF WARRANT MODIFICATION

 

   Original terms at August 19, 2021   Modified terms at August 19, 2021 
Volatility - range   109.3%   104.7%
Risk-free rate   0.78%   0.78%
Dividend   0%   0%
Remaining contractual term   4.5 years    5.1 years 
Exercise price  $3.25   $3.25 
Common stock issuable under the warrants   14,300,000    14,300,000 
SCHEDULE OF FAIR VALUE OF THE WARRANT DERIVATIVE LIABILITIES

The Company has utilized the following assumptions in its Black-Scholes option valuation model to calculate the estimated fair value of the warrant derivative liabilities as of their date of issuance and as of December 31, 2021:

 SCHEDULE OF FAIR VALUE OF THE WARRANT DERIVATIVE LIABILITIES

   Issuance date assumptions   December 31, 2021 assumptions 
Volatility - range   106.6166.6%   104.9%
Risk-free rate   0.08 - 0.49%   1.26%
Dividend   0%   0%
Remaining contractual term   0.01 - 5 years    4.04.7 years 
Exercise price  $2.80 - 3.25   $3.25 
Common stock issuable under the warrants   42,550,000    24,300,000 
SUMMARY OF WARRANT ACTIVITY

The following table summarizes information about shares issuable under warrants outstanding during the years ended December 31, 2021 and 2020:

 

   Warrants   Weighted
average
exercise price
 
Vested Balance, January 1, 2020   4,824,573   $5.15 
Granted   1,273,374    1.31 
Exercised   (2,704,583)   (1.95)
Cancelled   (5,000)   (16.50)
Vested Balance, December 31, 2020   3,388,364   $6.24 

 

   Warrants   Weighted
average
exercise price
 
Vested Balance, January 1, 2021   3,388,364   $6.24 
Granted   42,550,000    3.11 
Exercised   (18,250,000)   (2.92)
Cancelled   (1,679,766)   (9.42)
Vested Balance, December 31, 2021   26,008,598   $3.24 
SUMMARY OF RANGE OF EXERCISE PRICES AND WEIGHTED AVERAGE REMAINING CONTRACTUAL LIFE OF WARRANTS

The following table summarizes the range of exercise prices and weighted average remaining contractual life for outstanding and exercisable warrants to purchase common shares as of December 31, 2021:

 

    Outstanding and exercisable warrants 

Exercise

price

  

Number of

warrants

   Weighted average
remaining
contractual life
 
$2.60    465,712    1.6 years 
$3.00    316,800    1.3 years 
$3.25    24,300,000    4.4 years 
$3.36    733,333    0.9 years 
$3.65    167,000    0.5 years 
$3.75    25,753    0.6 years 
             
      26,008,598    4.2 years